Our programmable, scalable, and non-immunogenic nanocarriers can target tissues and cell types beyond the liver and highly outperform leading delivery technologies.
Our trained ML models predict carrier quality and performance to guide us in choosing the best candidates from a library of millions of distinct carriers. See Publication →
We are a team of passionate scientists and entrepreneurs, collaborating with expert scientific and business advisors.
News
August 20, 2024
Read More
News
August 16, 2024
Read More
Press Release
August 15, 2024
Read More
Publication
June 5, 2024
Read More
We are looking for exceptional individuals who want to push the frontiers of science and are driven by patient outcome. Check out our open positions or email us at careers@nuntiustx.com.
Nuntius Therapeutics Inc.
Delaware, United States
Nuntius Therapeutics Ltd.
London, United Kingdom